Delivery Order SPE2DB22D2108-SPE2DB25FU4DM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors valued at $3,161.04 on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $2,405.78 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on June 18, 2025, with a completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.91 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors. The award, issued on November 7, 2025, with a completion date of November 10, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,361.96 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by December 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,251.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on December 3, 2025, with completion required by December 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors valued at $2,934.71. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $34,843.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors. The contract, which is a child order under a larger indefinite delivery vehicle, has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,756.34 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with completion required by November 26, 2025. This firm fixed-price delivery order, issued on November 25, 2025, represents a non-competitive award under DLA's broader pharmaceutical procurement strategy and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the...
- The Defense Logistics Agency awarded a delivery order valued at $4,439.29 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors with a completion date of July 29, 2025. This firm fixed-price delivery order, issued on July 28, 2025, represents a competitively awarded contract with no set-aside designation. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,292.73 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors (0.5 mL) on December 4, 2025, with an ultimate completion date of December 5, 2025. This non-competitive, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU4DMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,394.53 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors on April 21, 2025, with completion expected by April 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's existing relationship with DLA for pharmaceutical supply. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As a prime contractor for DLA's comprehensive pharmaceutical supply program, AmerisourceBergen maintains authorization to deliver a wide range of medications and medical supplies to support military healthcare systems, Defense Health Agency operations, and other federal healthcare entities. The Mounjaro procurement exemplifies the company's role as a critical vendor for specialty pharmaceutical distribution within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.4k | 4/21/25 |